新天药业：控股股东减持公司股份达1%，持股比例下降

Core Viewpoint - The company Xintian Pharmaceutical announced that its controlling shareholder, Xintian Zhiyao, plans to reduce its holdings by no more than 7.05 million shares, accounting for 2.9962% of the total share capital after excluding shares in the repurchase special account [1] Summary by Sections - Shareholding Reduction Plan - Xintian Zhiyao intends to reduce its stake by up to 7.05 million shares, which represents 2.9962% of the total share capital after excluding repurchased shares [1] - Current Status of Share Reduction - As of November 12, Xintian Zhiyao has already reduced its holdings by 800,000 shares, which is 0.3277% of the total share capital and 0.3400% of the total share capital after excluding repurchased shares [1] - Impact on Shareholding Percentage - Following this reduction, Xintian Zhiyao's shareholding percentage decreased from 32.0809% to 31.7409%, with the change in equity reaching 1%, consistent with previous reduction plans and commitments [1]